🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06010199
Recruiting Observational

Risk Stratification Value of Biomarkers in Patients With Myocarditis

NCT06010199 · tracked via the Priya Life Science China tracker
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Phase
Observational
Started
2023-08-25
Last updated
2024-07-12

Condition(s) studied

Myocarditis

Study summary

The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.

Eligibility

Sex
ALL
Min age
3 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * All patients should meet the diagnostic criteria for myocarditis * Patients who are regularly followed up at the corresponding cardiovascular center Exclusion Criteria: * Age \<3 years or \>80 years * Pregnant or lactating women * The patient refused to sign the informed consent and refused to participate in the study * None of the above is consistent, but the patient cannot sign the informed consent temporarily due to coma and other reasons, and there is no legal representative to sign it instead. Depending on the condition, the patient may not wake up to sign the informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi Recruiting

More First Affiliated Hospital Xi'an Jiaotong University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06010199 on ClinicalTrials.gov ↗ ← All trials in China